Summary
The sample “Viamed 20” from DEUS Medical underwent qualitative and quantitative analysis. Testing confirmed the presence of Sildenafil Citrate with measured concentrations of 19.46 mg in the first pill and 19.88 mg in the second pill.
Testing was ordered and conducted on 7-8 July 2020.
Detailed Report
Product Overview
- Manufacturer: DEUS Medical
- Product Name: Viamed 20
- Active Ingredient: Sildenafil Citrate
- Batch Number: DM52608
- Expiration Date: Not provided
- Delivery Method: Oral
Sample Acquisition and Testing
- Task Number: #07042
- Testing Ordered: 7 July 2020
- Sample Received: 7 July 2020
- Analysis Conducted By: Janoshik Analytical
- Submitted By: DEUSPOWER.COM
- Analysis Paid For By: DEUSPOWER.COM
Testing Results
- Identified Compound: Sildenafil Citrate
- First Pill Concentration: 19.46 mg
- Second Pill Concentration: 19.88 mg
Verification Details
- Verification URL: https://janoshik.com/tests/07042_VUBVAEF471IH
Evaluation of Reseller-Submitted Testing
The test confirms the presence of Sildenafil Citrate in the Viamed 20 pills with minor dosage variations (19.46 mg and 19.88 mg), which are within acceptable manufacturing tolerances for pharmaceuticals.
Conclusion
The results validate the presence and dosage of Sildenafil Citrate in the sample, demonstrating compliance with the expected formulation standards.
Disclaimer
This report is for informational purposes and reflects findings based on reseller-submitted testing. Independent third-party analysis is recommended for thorough validation.
